Dr. Bruce D. Forrest has been appointed chief development officer at Omni Bio Pharmaceutical, Inc. Dr. Forrest currently serves as president of B D Forrest & Co., Inc., a pharma/biopharma consulting firm that provides scientific strategy and business development support, and has worked with Omni Bio during the past year.    In his expanded role, he will oversee the development plan for Omni Bio’s lead Fc fusion recombinant AAT molecule for the potential treatment of type 1 diabetes, gr...